Our sponsors

We would like to acknowledge and thank the sponsors listed below, without whom the Congress would not be possible.

CIRTA Takeda logo

Platinum sponsor | Takeda

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

CIRTA Baxter logo

Gold sponsor | Baxter

Through our Mission of Saving and Sustaining Lives, Baxter is committed to improving outcomes for patients, and helping healthcare professionals meet the evolving challenges and opportunities in Australia and New Zealand, and around the world. Our work includes educating patients, training healthcare professionals and sharing best practices to enhance patient safety and drive improved patient outcomes.

We offer a comprehensive portfolio of products for acute and chronic patients who are unable to take adequate oral or enteral nutrition, or require supplemental nutrition.

Our nutrition product portfolio includes several nutritionally balanced, ready-to-use parenteral nutrition formulations as well as a pharmacy workflow and compounding technology, to support more complex, individualised nutritional requirements.

CIRTA Stanford Childrens Health logo

Silver sponsor | Stanford Children's Health

Lanyard and name badge sponsor

The vision of the Pediatric Transplant Center at Stanford Children’s Health is to provide the world’s best organ transplantation care to children and their families by a combination of innovation, collaboration, compassion, and perseverance.

Our Pediatric Transplant Center excels at handling the toughest challenges. We provide high-touch care to high acuity cases for children needing all types of transplants, including heart, lung, liver, kidney, intestine and combined transplants.

Our physicians and scientists are developing new ways to manage immunosuppression so that transplant patients can live longer, fuller lives. Advances in bioengineering, stem cell therapy, genetics and personalized medicine will further improve things for our young patients for years to come.

CIRTA Fresenius Kabi

Bronze sponsor | Fresenius Kabi

Session 1 sponsor

Fresenius Kabi is a global health care company that specialises in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.

Our product portfolio comprises of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, we focus on autoimmune diseases. Fresenius Kabi offers products for collection of blood components and cell therapies.

CIRTA Hanmi Pharm logo

Associate sponsor | Hanmi Pharm

Hanmi Pharm established in 1973 has a motto ‘to develop better drugs for precious lives’ and to advance to the global market as a representative of the Korean Pharmaceutical industry by focusing on R&D. Hanmi’s first mission, ‘respect for human life, value creation’, is creating new values to keep everyone’s health and improve their quality of life. Hanmi makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone’s health and improve their quality of life.

CIRTA Tauropharm logo

Associate sponsor | TauroPharm

In 2000, TauroPharm GmbH was founded as a German company specialising in medical devices with antimicrobial, antibiofilm and antiocclusive efficacy.

Based on its innovative products, we aim to develop more effective ways to prevent catheter-associated complications – ranging from blood clotting to fatal infections.

Throughout this process, improving the patient’s quality of life remains our top priority.

Since there is an urgent need for our products, especially in light of the steadily increasing number of antibiotics-resistant pathogens, TauroLock is recommended in interdisciplinary national and international guidelines.

All products have been investigated in independent scientific studies with excellent study results.